Results 11 to 20 of about 2,904 (112)
Role of RWD / RWE in health technology assessment
Реальная клиническая практика: данные и доказательства, 2023 For many reasons randomized clinical trials today can»t cope with the tasks set by modern health care, which was clearly demonstrated by the COVID-19 pandemic. This gave new impetus to the development of the RWD / RWE.
V. G. Borovskaya, A. A. Kurylev
doaj +1 more source
The role of real world data and real world evidence in health technology assessment
Фармакоэкономика, 2022 Real world data (RWD) and real world evidence (RWE) is one of the most rapidly developing areas in the modern health care systems, which is caused by the development of technologies for both collecting and analyzing data, the emergence of new data ...
E. A. Novoderezhkina, S. К. Zyryanov
doaj +1 more source
International Journal of Technology Assessment in Health Care, 2012 This issue of the International Journal of Technology Assessment in Health Care (IJTAHC) brings to the readers a lively discussion on the possibility of benchmarking health technology assessment (HTA) organizations. Michael Drummond and colleagues present a paper discussing “the conceptual and methodological challenges associated with benchmarking” (1).
openaire +2 more sources
Sağlık ve Hemşirelik Yönetimi Dergisi, 2020 INTRODUCTION: In this study, it was aimed to evaluate the views and opinions of the health administrators, who are working in the private hospitals in Konya province centre about health technology assessment and applications.
Mehmet Akif Erişen +1 more
doaj +1 more source
CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
Molecules, 2023 C-X-C chemokine receptor type 4 (CXCR4), also known as fusin or CD184, is a 7-transmembrane helix G-protein-coupled receptor that is encoded by the CXCR4 gene.
Jingjing Yu, Xu Zhou, Langtao Shen
doaj +1 more source
International Journal of Technology Assessment in Health Care, 2010 Paul Trueman and colleagues (3) have reported on an important issue. Several HTAs on the same topic have been published recently. They have examined four recent HTA reports on drug-eluting stents (DES), demonstrating varying methods and conclusions. All four HTAs included local registry data and economic evaluations in addition to analyses of published
Iris Pasternack +6 more
openaire +3 more sources
Societies, 2020 Prosthetic technology for people with missing limbs has made great progress in recent decades. However, acceptance rates and user satisfaction are not only dependent on technical aspects, but also to a great extent on social and psychological factors. We
Martina F. Baumann +3 more
doaj +1 more source
Ethics in HTA: Examining the "Need for Expansion" [PDF]
International Journal of Health Policy and Management, 2017 The article by Daniels and colleagues on expanding the scope of health technology assessment (HTA) to embrace ethical analysis has received endorsement and criticism from commentators in this journal. Referring to this debate, we examine in this article the extent and locus of ethical analysis in HTA processes.
Abrishami, Payam +2 more
openaire +3 more sources
HTA – Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy" [PDF]
International Journal of Health Policy and Management, 2016 Daniels, Porteny and Urrutia et al make a good case for the idea that that public decisions ought to be made not only "in the light of" evidence but also "on the basis of" budget impact, financial protection and equity. Health technology assessment (HTA) should, they say, be accordingly expanded to consider matters additional to safety and cost ...
openaire +5 more sources
Фармакоэкономика, 2018 In the article, we analyze the current version of Government Regulation No. 871 where the principles of health technologies assessment (HTA) and the reimbursement strategies in Russia have been put forward.
V. V. Omelyanovsky +2 more
doaj +1 more source